Volume 6, Issue 2 (4-2023)                   Mod Med Lab J 2023, 6(2): 8-12 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rahmanifar F, Mussin N, Tamadon A. Advances in mesenchymal stromal/stem cell therapy for non-obstructive azoospermia: a comprehensive mini-review. Mod Med Lab J 2023; 6 (2) :8-12
URL: http://modernmedlab.com/article-1-142-en.html
Abstract:   (92 Views)
Azoospermia, characterized by the absence of sperm in semen, poses a significant challenge to male fertility. Mesenchymal stromal/stem cell (MSC) therapy has emerged as a promising approach for treating azoospermia by promoting spermatogenesis and restoring fertility. MSCs possess the ability to differentiate into male germ cells and create a favorable microenvironment for spermatogenesis through the secretion of growth factors and cytokines. Preclinical studies have shown encouraging results, with improved testicular histology, sperm production, and fertility outcomes in animal models of azoospermia. Limited clinical studies in humans have also demonstrated the potential of MSC therapy in restoring spermatogenesis. However, challenges such as standardization of MSC isolation, characterization, and administration protocols, as well as the need for long-term safety and efficacy data, remain to be addressed. Despite these challenges, MSC therapy holds great promise for the treatment of azoospermia and warrants further research to optimize its use in clinical practice.
Full-Text [PDF 223 kb]   (36 Downloads)    

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Modern Medical Laboratory Journal